Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Post Hoc Analysis of the Correlation Between Patient-Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis ; volume:9 ; number:2 ; day:17 ; month:12 ; year:2021 ; pages:435-446 ; date:4.2022
Rheumatology and therapy ; 9, Heft 2 (17.12.2021), 435-446, 4.2022
- Creator
-
Fleischmann, Roy
Hayes, Kyle
Ahn, Sung-Woo
Wan, George J.
Panaccio, Mary P.
Karlsson, Daniel
Furst, Daniel E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-021-00412-x
- URN
-
urn:nbn:de:101:1-2022061809232813784913
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fleischmann, Roy
- Hayes, Kyle
- Ahn, Sung-Woo
- Wan, George J.
- Panaccio, Mary P.
- Karlsson, Daniel
- Furst, Daniel E.
- SpringerLink (Online service)
Other Objects (12)
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis
Repository corticotropin for Chronic Pulmonary Sarcoidosis
Patient-Reported Outcomes from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial
Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Correction to: Repository Corticotropin Injection for Persistently Active Systemic Lupus Erythematosus: Results from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Repository Corticotropin in Treating de novo C3 Glomerulonephritis after Transplantation
Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus
Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Efficacy and tolerability of subcutaneous repository corticotropin injection in refractory ocular inflammatory diseases